CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection

The CD40–CD40 ligand (CD40L) dyad represents a scientific and clinical field that has raised many controversies in the past and cannot be clearly defined as being an either beneficial or harmful pathway. Being crucially involved in physiological immunological processes as well as pathological inflam...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	International journal of molecular sciences Ročník 21; číslo 22; s. 8533
Hlavní autoři:	Daub, Steffen, Lutgens, Esther, Münzel, Thomas, Daiber, Andreas
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland MDPI AG 12.11.2020 MDPI
Témata:	Animals Atherosclerosis Atherosclerosis - metabolism Autoimmune Diseases - metabolism Binding sites Biomarkers Cardiovascular disease Cardiovascular Diseases - metabolism Cardiovascular System CD40 Antigens - metabolism CD40 Ligand - metabolism Clinical Trials as Topic Cytokines Diabetes Gene Silencing Heart attacks Humans Hypertension Immunomodulators Inflammation Kinases Ligands Lupus Mice Mice, Transgenic Proteins Psoriasis Review Rheumatoid arthritis Risk Factors Signal Transduction Smooth muscle Thrombosis Tumor necrosis factor-TNF atherosclerosis cardiovascular disease CD40 inflammation CD40 ligand
ISSN:	1422-0067, 1661-6596, 1422-0067
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!